{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260529154810/en/U.S.-Food-and-Drug-Administration-Accepts-for-Priority-Review-Bristol-Myers-Squibb%E2%80%99s-Supplemental-New-Drug-Application-for-Camzyos-mavacamten-to-Treat-Adolescents-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-oHCM", "message": "News view counter 769554 successfully enlarged"}